As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.

The Oncology & Immunology Unit (OIU) works efficiently with partners through our leading biology research service platform. We cover all of your research needs ranging from target discovery, in vitro and in vivo pharmacology, and translational research to clinical biomarker testing enabling drug discovery for cancer, autoimmune disease and rare genetic diseases (RGD). Learn more about OIU here.

Job Location: Suzhou, China

• Take the lead to build the cell biology/biochemistry (kinase biology) testing platform; responsible for writing related SOP and ensure it is properly executed.
• As a potential platform leader, take the managerial ownership to offer insights, initiatives and strategies in team building.
• As project leader, responsible for study design, resource allocation, by which to make sure the successful completion of projects.
• Participate in multi-tiered projects’ milestone planning meeting, collaborate closely with other group leaders and platform leaders.
• Obligated to guide and supervise team member’s work and responsible for team members' talent development 

• Ph.D. in cell biology, molecular biology, immunology, oncology or other life science field (MS with rich industry experiences is also preferable); Extensive research experience in oncology and target discovery is a plus.
• Profound knowledge in cell biology/kinase biology; master skills and techniques in cell biology includes but not limited to HTRF, AlphaLISA, ADP-Glo, et al; bench work experience is a must; 5-10 years of relevant experience in innovative pharmaceutical/biotech company is a plus.
• Experience in gene cloning, protein expression, cell culture, and generation of transient/stable cell lines. Experience in CRISPR/Cas9, RNAi is a plus.
• Highly motivated, work independently, strong analytical skills and summarizing strategies is preferred. Creative research achievement is a plus, e.g. Publication in high-ranking journal.
• Fluent oral/written Chinese and English; proven experience in team management.